Vectra Magnetic Resonance System
by General Electric Co. 2 variants
510(k) K913673
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK913673 | Date23 Jan 1992 | StatusActive |
Recalls
-
- Ongoing Z-0618-2022
The magnetic resonance systems could potentially have a cryogen ventilation system that does not meet the venting requirements.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LNH
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1000
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Vectra Magnetic Resonance System is a System, Nuclear Magnetic Resonance Imaging device. It is classified as a Class II medical device under product code LNH.
The device received FDA 510(k) clearance (K913673) on January 23, 1992, following a traditional review. It is manufactured by General Electric Co. in Milwaukee, US, and is subject to special controls under regulation number 892.1000.
Other devices from General Electric Co.
Questions
AI-generated answers, 1 Oct 2026
What is the Vectra Magnetic Resonance System used for?
The Vectra Magnetic Resonance System is a nuclear magnetic resonance imaging device intended for diagnostic imaging procedures that use magnetic fields and radio waves to produce detailed images of internal body structures, as indicated by its product code LNH and classification under regulation 892.1000 for radiology applications.
Who manufactures the Vectra Magnetic Resonance System and where is it made?
The Vectra Magnetic Resonance System is manufactured by General Electric Co. at their facility in Milwaukee, Wisconsin, United States, as specified in the device data showing the manufacturer location and address details.
What regulatory pathway was used for the Vectra Magnetic Resonance System's market authorization?
The Vectra Magnetic Resonance System received market authorization through the FDA 510(k) traditional review process, with clearance granted under K913673 on January 23, 1992, following a determination of substantial equivalence to a legally marketed predicate device.